Book Value Per Share: The amount of equity available to shareholders expressed on a per common share basis. Calculated as: Total Shareholders Equity / Common Shares Outstanding
Myriad Genetics, Inc. (MYGN) had Book Value Per Share of $2.81 for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$202.70M |
|
$-43.90M |
|
$65.00M |
|
$137.70M |
|
$242.60M |
|
$-39.90M |
|
$-3.70M |
|
$-43.60M |
|
$-43.60M |
|
$-43.90M |
|
$-43.90M |
|
$-43.90M |
|
$-43.90M |
|
$-39.90M |
|
$-27.30M |
|
95.70M |
|
95.70M |
|
$-0.46 |
|
$-0.46 |
|
| Balance Sheet Financials | |
$271.90M |
|
$104.70M |
|
$337.30M |
|
$609.20M |
|
$137.60M |
|
$121.10M |
|
$202.60M |
|
$340.20M |
|
$269.00M |
|
$90.10M |
|
$269.00M |
|
95.70M |
|
| Cash Flow Statement Financials | |
$-30.50M |
|
$-11.80M |
|
$-1.10M |
|
$151.30M |
|
$107.80M |
|
$-43.50M |
|
$22.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.98 |
|
-- |
|
-- |
|
0.31 |
|
0.45 |
|
67.93% |
|
-19.68% |
|
-19.68% |
|
-- |
|
-21.51% |
|
-21.66% |
|
$-39.80M |
|
-- |
|
-- |
|
-- |
|
0.33 |
|
2.27 |
|
1.92 |
|
46.84 |
|
-16.32% |
|
-48.72% |
|
-7.21% |
|
-11.25% |
|
|
Book Value Per Share |
$2.81 |
$-0.42 |
|
$-0.32 |
|